LAURA LARRÚ

MSc Biochemistry, BS Biology 

Laura Larrú is a pharmacovigilance consultant with over 10 years of experience in multinational pharmaceutical companies.

She started her professional career in Procter & Gamble Pharmaceuticals developing different roles as Regulatory Affairs and Pharmacovigilance Manager. In 2011 she joined Alcon (Novartis) where she was dedicated to Drug safety, Global Safety Labeling and to the development and implementation of Company Core Safety Information (CCSIs) in international markets. During that stage, she was a key member in the creation of the company set of CCSIs covering more than 70 products and including the preparation of supporting documents with the integration of drug safety data from clinical trials, toxicology, pharmacokinetics, post-marketing surveillance and the literature.

Laura has a very solid experience in the development of Key Performance Indicators (KPIs), SOPs, Pharmacovigilance Agreements (PVAs) and knowledge in relevant guidelines and regulations. Her experience also includes delivering training on compliance and pharmacovigilance best practices.

She contributed to many successful cross-functional and international projects such as the harmonization of safety data sheets for Shared Medicinal Products between company’s cross-sectors and the questions and answer process with many regulatory authorities including the EMA. 

Since 2013 she has been speaker at Postgraduate Courses from the University of Barcelona.

Laura Larrú received a bachelor’s degree in Biology and a M.Sc. in Biochemistry from the University of Barcelona. She performed part of her research project in Molecular Biology in the Netherlands Cancer Institute.